|
1
|
Quinton,
R., Duke, VM., de Zoysa , PA. , Platts, AD., Valentine, A., Kendall ,
B., Pickman, S., Kirk, JM., Besser, GM, Jacobs, HS. and Bouloux , PM .
(1996) The neuroradiology of Kallmann's syndrome: a genotypic and
phenotypic analysis. J Clin Endocrinol Metab : 81(8):3010-7.
|
|
2
|
Robertson,
A., MacColl, GS., Nash, JA., Boehm, MK., Perkins, SJ., Bouloux , PM .
(2001) Molecular modelling and experimental studies of mutation and
cell-adhesion sites in the fibronectin type III and whey acidic protein
domains of human anosmin-1. Biochem J : 1:357(Pt 3):647-59.
|
|
3
|
MacColl, G., Bouloux , P ., Quinton, R. (2002) Kallmann Syndrome: adhesion, afferents and anosmia. Neuron : 34: 675-678.
|
|
4
|
Hu,
Youli, Gonzalez-Martinez D., Kim Soo-Hyun., Bouloux PMG . (2004)
Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's
syndrome, with heparan sulphate and urokinase-type plasminogen
activator. Biochem J : 384:1-11.
|
|
5
|
Gonzalez-Martinez
D., Kim S., Hu Y., Guimond , S., Vannelli, B., Turnbull , J., Bouloux
,PMG (2004). Anosmin-1 modulates FGFR1 signalling in human GnRH
olfactory neuroblasts through a heparan sulphate-dependent mechanism. Journal of Neuroscience: 24 (47):4-15
|
